You are viewing a single comment's thread from:

RE: $600 EpiPen 2-Pack for Anaphylactic Shock has ONE MORE Competitor!

in #health8 years ago

Yeah, it is great for the end consumer when a cheaper generic is made. On the flipside those companies are not long-term growth investments. Tradeable moments and good will with society.

Sort:  

yeah, unfortunately a sad reality, but I suppose it is what it is.